Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kristoffer Jarlov Jensen, Camilla Bjørn Jensen, Christina Wennerström, Johan Burisch & Janne Petersen. (2023) Drug utilization of biologic therapy in Crohn’s disease and ulcerative colitis: a population-based Danish cohort study 2015–2020. Scandinavian Journal of Gastroenterology 58:7, pages 726-736.
Read now
Read now
Ala I Sharara, Samir Al Awadhi, Othman Alharbi, Hisham Al Dhahab, Mohamed Mounir, Leonardo Salese, Ena Singh, Nancy Sunna, Nadine Tarcha & Mahmoud Mosli. (2018) Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East. Expert Review of Gastroenterology & Hepatology 12:9, pages 883-897.
Read now
Read now
Alexandre Gherardi, Stéphane Roze, Johan Kuijvenhoven, Ola Ghatnekar & Yum Lina Yip Sonderegger. (2018) Budesonide with multi-matrix technology as second-line treatment for ulcerative colitis: evaluation of long-term cost-effectiveness in the Netherlands. Journal of Medical Economics 21:9, pages 869-877.
Read now
Read now
Yu-Sheng Zhang, Feng Wang, Shu-Xiang Cui & Xian-Jun Qu. (2018) Natural dietary compound naringin prevents azoxymethane/dextran sodium sulfate-induced chronic colorectal inflammation and carcinogenesis in mice. Cancer Biology & Therapy 19:8, pages 735-744.
Read now
Read now
Carolina L. Bellera, Mauricio E. Di Ianni & Alan Talevi. (2018) The application of molecular topology for ulcerative colitis drug discovery. Expert Opinion on Drug Discovery 13:1, pages 89-101.
Read now
Read now
Articles from other publishers (12)
Heba A. Hassan, Amira Mohamed abdelhamid, Walaa Samy, Heba Osama Mohammed, Samar Mortada Mahmoud, Amal fawzy abdel mageed & Noha A.T. Abbas. (2024) Ameliorative effects of androstenediol against acetic acid-induced colitis in male wistar rats via inhibiting TLR4-mediated PI3K/Akt and NF-κB pathways through estrogen receptor β activation. International Immunopharmacology 127, pages 111414.
Crossref
Crossref
Allie Cichewicz, Tom Tencer, Komal Gupte-Singh, Sonya Egodage, Heather Burnett & Jinender Kumar. (2023) A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis. Advances in Therapy 40:5, pages 2116-2146.
Crossref
Crossref
Rami B. Kassab, Mohamad Elbaz, Atif A. A. Oyouni, Ahmad H. Mufti, Abdulrahman Theyab, Ashraf Al-Brakati, Hala A. Mohamed, Ali M. S. Hebishy, Mohammed I. Y. Elmallah, Mohamed S. Abdelfattah & Ahmed E. Abdel Moneim. (2022) Anticolitic activity of prodigiosin loaded with selenium nanoparticles on acetic acid–induced colitis in rats. Environmental Science and Pollution Research 29:37, pages 55790-55802.
Crossref
Crossref
Danny Con, Bridgette Andrew, Steven Nicolaides, Daniel R van Langenberg & Abhinav Vasudevan. (2022) Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy. Intestinal Research 20:1, pages 101-113.
Crossref
Crossref
Millie D. Long, Russell D. Cohen, Timothy W. Smith, Marco DiBonaventura, David Gruben, Danielle Bargo, Leonardo Salese & Daniel Quirk. (2022) Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis. Digestive Diseases 40:5, pages 553-564.
Crossref
Crossref
Walter Reinisch, William J Sandborn, Silvio Danese, Xavier Hébuterne, Maria Kłopocka, Dino Tarabar, Tomáš Vaňásek, Miloš Greguš, Paul A Hellstern, Joo Sung Kim, Miles P Sparrow, Kenneth J Gorelick, Michael Hoy, Martina Goetsch, Caleb Bliss, Charu Gupta, Fabio Cataldi & Séverine Vermeire. (2021) Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II. Journal of Crohn's and Colitis 15:6, pages 938-949.
Crossref
Crossref
Priya Sehgal, Ryan C Ungaro, Carol Foltz, Brian Iacoviello, Marla C Dubinsky & Laurie Keefer. (2021) High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 27:6, pages 791-796.
Crossref
Crossref
Mehrez E. El-Naggar, Jihan Hussein, Samah M. El-sayed, Ahmed M. Youssef, Mona El Bana, Yasmin Abdel Latif & Dalia Medhat. (2020) Protective effect of the functional yogurt based on Malva parviflora leaves extract nanoemulsion on acetic acid-induced ulcerative colitis in rats. Journal of Materials Research and Technology 9:6, pages 14500-14508.
Crossref
Crossref
Chau M. Hoang, Justin A. Maykel, Jennifer S. Davids, Allison S. Crawford, Paul R. Sturrock & Karim Alavi. (2020) Distribution of Elective Ileal Pouch-Anal Anastomosis Cases for Ulcerative Colitis: a Study Utilizing the University Health System Consortium Database. Journal of Gastrointestinal Surgery 24:11, pages 2613-2619.
Crossref
Crossref
Shimaa M. Elshazly, Ahmed E.M. Elhassanny & Nevertyty M. Mahmoud. (2020) Cilostazol protects against acetic acid-induced colitis in rats: Possible role for cAMP/SIRT1 pathway. European Journal of Pharmacology 881, pages 173234.
Crossref
Crossref
Luis Hernandez, Hiroyo Kuwabara, Anshul Shah, Kaoru Yamabe, Heather Burnett, Kyle Fahrbach, Maria Koufopoulou & Ryuichi Iwakiri. (2019) Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan. PharmacoEconomics 38:1, pages 69-84.
Crossref
Crossref
Garima Juyal, Ajit Sood, Vandana Midha & B. K. Thelma. (2018) Genetics of ulcerative colitis: putting into perspective the incremental gains from Indian studies. Journal of Genetics 97:5, pages 1493-1507.
Crossref
Crossref